Organogenesis Long Term Debt Total vs Intangible Assets Analysis
ORGO Stock | USD 2.75 0.02 0.73% |
Organogenesis Holdings financial indicator trend analysis is much more than just breaking down Organogenesis Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Organogenesis Holdings is a good investment. Please check the relationship between Organogenesis Holdings Long Term Debt Total and its Intangible Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organogenesis Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
Long Term Debt Total vs Intangible Assets
Long Term Debt Total vs Intangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Organogenesis Holdings Long Term Debt Total account and Intangible Assets. At this time, the significance of the direction appears to have weak relationship.
The correlation between Organogenesis Holdings' Long Term Debt Total and Intangible Assets is 0.39. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Organogenesis Holdings, assuming nothing else is changed. The correlation between historical values of Organogenesis Holdings' Long Term Debt Total and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of Organogenesis Holdings are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Long Term Debt Total i.e., Organogenesis Holdings' Long Term Debt Total and Intangible Assets go up and down completely randomly.
Correlation Coefficient | 0.39 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Long Term Debt Total
Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Most indicators from Organogenesis Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Organogenesis Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organogenesis Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.At this time, Organogenesis Holdings' Tax Provision is very stable compared to the past year. As of the 2nd of June 2024, Sales General And Administrative To Revenue is likely to grow to 0.67, while Selling General Administrative is likely to drop about 146.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 114.2M | 105.0M | 123.4M | 69.0M | Research Development | 30.7M | 39.8M | 44.4M | 46.6M |
Organogenesis Holdings fundamental ratios Correlations
Click cells to compare fundamentals
Organogenesis Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Organogenesis Holdings fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 220.7M | 294.5M | 443.3M | 449.4M | 460.0M | 292.5M | |
Other Current Liab | 5.8M | 2.1M | 2.3M | 26.4M | 30.1M | 31.6M | |
Total Current Liabilities | 59.9M | 68.2M | 82.0M | 75.0M | 80.5M | 48.2M | |
Total Stockholder Equity | 55.6M | 146.1M | 242.0M | 265.7M | 278.7M | 179.4M | |
Other Liab | 7.7M | 15.7M | 1.6M | 1.1M | 1.3M | 1.2M | |
Net Tangible Assets | 9.2M | 86.7M | 187.6M | 216.1M | 248.5M | 261.0M | |
Retained Earnings | (171.0M) | (153.1M) | (60.1M) | (45.3M) | (41.0M) | (43.0M) | |
Accounts Payable | 28.4M | 23.4M | 29.3M | 32.3M | 30.7M | 23.8M | |
Cash | 60.2M | 84.4M | 113.9M | 102.5M | 104.3M | 53.7M | |
Other Assets | 1.6M | 688K | 33.5M | 31.5M | 1.0 | 0.95 | |
Long Term Debt | 83.1M | 53.0M | 70.8M | 66.2M | 60.7M | 65.7M | |
Net Receivables | 39.4M | 56.8M | 82.5M | 89.5M | 82.0M | 52.7M | |
Common Stock Total Equity | 293.0M | 9K | 10K | 13K | 11.7K | 11.1K | |
Inventory | 22.9M | 27.8M | 25.0M | 24.8M | 28.3M | 20.8M | |
Other Current Assets | 3.0M | 4.9M | 5.0M | 5.1M | 10.5M | 11.0M | |
Other Stockholder Equity | 226.6M | 299.1M | 302.2M | 311.0M | 319.6M | 181.3M | |
Total Liab | 165.1M | 148.4M | 201.2M | 183.7M | 181.4M | 113.0M | |
Deferred Long Term Liab | 318K | 92K | 370K | 1.2M | 1.4M | 1.5M | |
Total Current Assets | 125.6M | 174.3M | 227.0M | 222.6M | 225.0M | 115.3M | |
Short Term Debt | 3.1M | 20.3M | 14.6M | 16.2M | 19.7M | 20.7M | |
Intangible Assets | 20.8M | 30.6M | 25.7M | 20.8M | 15.9M | 22.1M | |
Common Stock | 293.0M | 9K | 10K | 13K | 11.7K | 11.1K | |
Property Plant Equipment | 47.2M | 60.1M | 79.2M | 102.5M | 117.8M | 123.7M | |
Short Long Term Debt Total | 100.6M | 84.8M | 132.3M | 123.8M | 119.4M | 85.3M | |
Net Debt | 40.4M | 377K | 18.4M | 21.3M | 15.0M | 16.2M | |
Non Current Assets Total | 95.1M | 120.2M | 216.3M | 226.8M | 235.0M | 196.6M | |
Non Currrent Assets Other | 884K | 670K | 1.5M | 1.5M | 6.0M | 5.7M | |
Cash And Short Term Investments | 60.2M | 84.4M | 113.9M | 102.5M | 104.3M | 59.6M | |
Common Stock Shares Outstanding | 92.8M | 111.4M | 133.7M | 132.4M | 132.7M | 105.4M | |
Liabilities And Stockholders Equity | 220.7M | 294.5M | 443.3M | 449.4M | 460.0M | 324.6M | |
Non Current Liabilities Total | 105.2M | 80.2M | 119.2M | 108.7M | 100.9M | 71.7M | |
Capital Surpluse | 226.6M | 299.1M | 302.2M | 311.0M | 357.6M | 182.7M | |
Non Current Liabilities Other | 6.6M | 12.0M | 48.5M | 42.4M | 1.2M | 1.2M | |
Net Invested Capital | 138.7M | 215.8M | 315.5M | 336.4M | 344.9M | 273.1M | |
Net Working Capital | 65.7M | 106.1M | 145.0M | 147.6M | 144.5M | 95.9M | |
Property Plant And Equipment Net | 47.2M | 60.1M | 128.3M | 145.7M | 156.3M | 105.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organogenesis Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Organogenesis Stock analysis
When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
CEOs Directory Screen CEOs from public companies around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Global Correlations Find global opportunities by holding instruments from different markets |
Is Organogenesis Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.307 | Earnings Share 0.04 | Revenue Per Share 3.313 | Quarterly Revenue Growth 0.022 | Return On Assets 0.0201 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.